Top Markets
#1 EXOD EXOD +56.80%
#2 Arowana Arowana +8.48%
#3 Harmony Harmony +7.27%
#4 Fake World Assets Fake World Assets +6.48%
#5 Cysic Cysic +5.83%
#6 Orochi Network Orochi Network +3.92%
#7 Dual Dual +3.59%
#8 Fabric Protocol Fabric Protocol +3.54%
#9 Figure Heloc Figure Heloc +3.49%
#10 TAGGER TAGGER +3.35%
Coin of the day
EXOD EXOD
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Roquefort Therapeutics plc Roquefort Therapeutics plc

Roquefort Therapeutics plc

ROQ
Rang in aandelen #37956
Roquefort Therapeutics plc functions as a biotechnology firm, focusing its... Roquefort Therapeutics plc functions as a biotechnology firm, focusing its efforts on the discovery and development of innovative pharmaceutical treatments. The company's primary research objective is to develop therapies that target Midkine, a circulating growth factor protein and pro-inflammatory mediator, for applications in cancer treatment. Established in 2020, Roquefort Therapeutics plc has its main operations based in London, United Kingdom.
Aandeelprijs
$0.10205262
Laatst gesynchroniseerd: 2026-04-23
Marktkapitalisatie
$1.32M
Verandering (1 dag)
5.19%
Verandering (1 jaar)
-54.38%
Land
GB
Handel Roquefort Therapeutics plc (ROQ)

Categorie

Healthcare
Dividendrendementgeschiedenis voor Roquefort Therapeutics plc (ROQ)
Het dividendrendement (TTM) van Roquefort Therapeutics plc (aandelsymbool: ROQ) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Roquefort Therapeutics plc (ROQ) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten
Bedrijf Dividendrendement Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
0.65%
BE